With the emergence and long-term Impact of COVID-19, the Global Antiemetics Market is to reach USD 3.92 Billion by 2030
Bizwit Research & Consulting LLP’s Recent Analysis on Global Antiemetics Market is poised to raise up to USD 3.92 Billion by 2030. Antiemetics is a group of drugs used to treat or prevent nausea and vomiting, which are frequent side effects of many different medical illnesses, treatments, and drugs. An antiemetic is a type of medication that lessens nausea and vomiting. The adverse effects of opioid analgesics, general anesthetics, and chemotherapy are frequently treated with them. It is used to treat conditions including motion sickness, pregnancy, food poisoning, and dizziness in patients.
The growing prevalence of nausea and vomiting, surge in research and development activities and identification of new drug targets, increasing healthcare expenditure, and rising health consciousness among people, coupled with the rising number of hospitals are the key factors that are associated with the market growth during the estimated period. The increasing prevalence of cancer and gastroenteritis worldwide is playing a vital role in bolstering the market demand across the globe. Chemotherapy and radiation therapy are standard treatments for cancer. However, these treatments often cause significant nausea and vomiting as side effects. The increasing adoption of these therapies, along with the need to effectively manage treatment-related symptoms, drives the demand for antiemetic medications.
The GLOBOCAN stated that, in 2020, it was estimated that approximately 19.3 million new cases of cancer were reported globally and the figure is anticipated to rise to 30.2 million by 2040. Thus, these aforementioned factors are propelling the growth of the Antiemetics Market during the estimated period. Moreover, the rising technological advancements in drug delivery systems, as well as the expanded use of antiemetics in non-oncology settings present various lucrative opportunities over the forecast years. However, the less awareness about antiemetic drugs among the population and the unavailability of suitable animal models are challenging the market growth throughout the forecast period of 2023-2030.
Geographically, the global Antiemetics Market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the rising inclination towards chemotherapy and radiation therapy, increasing focus on advancements in antiemetic drug development, and the presence of well-established market players. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing geriatric population, increasing prevalence of nausea and vomiting, and expanded use of antiemetics in non-oncology settings are significantly propelling the market demand across the region.
The global Antiemetics Market is highly competitive owing to the presence of several key manufacturers such as Novartis AG, GlaxoSmithKline Plc, Cipla Limited, Acacia Pharma Group Plc, Dr. Reddy’s Laboratories Ltd, Sanofi, Merck & Co. Inc., and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Antiemetics Market is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2023-2030.
- In the Application segment, chemotherapy emerged as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to the growing emphasis on advancements in antiemetic drug development.
- Asia Pacific is expected to grow at a high CAGR followed by North America during 2023-2030.
Bizwit Research & Consulting has considered the following segments for the study:
By Drug Type:
- Antihistamines
- Serotonin Receptor Antagonists
- Dopamine Receptor Antagonists
- Neurokinin Receptor Antagonists
- Anticholinergics
- Other Drug Types
By Application:
- Chemotherapy
- Post Operative Surgery
- Pregnancy and Gatroenteritis
- Other Applications
By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone : +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
